grant
Characterizing genetic risk of cancer across diverse populations through multi-ancestry epigenome profiling and chromatin QTL discovery
Organization DANA-FARBER CANCER INSTLocation BOSTON, UNITED STATESPosted 1 Apr 2025Deadline 31 Mar 2030
NIHUS FederalResearch GrantFY2026AffectAfricaAfrican AmericanAfrican ancestryAfrican descentAfro AmericanAfroamericanAsian groupAsian individualAsian peopleAsian populationAsiansBiologicalBlood PlasmaBreast CancerCancersCell BodyCellsChIP SequencingChIP-seqChIPseqChromatinClinicalColon CancerColon CarcinomaDNADataData SetDeoxyribonucleic AcidDevelopmentDiseaseDisorderDisparitiesDisparityDisproportionate number of menDisproportionately impacts malesDisproportionately in menEpigeneticEpigenetic ChangeEpigenetic MechanismEpigenetic ProcessEuropean ancestryGWA studyGWASGene Action RegulationGene Expression RegulationGene FrequencyGene RegulationGene Regulation ProcessGene variantGeneticGenetic DiversityGenetic ResearchGenetic RiskGenetic VariationGenetic studyGenotypeGoalsHispanic PopulationsHispanic groupHispanic individualHispanic peopleHispanicsIncidenceIndividualInvestigatorsLatinoLatino PopulationLatino groupLatino individualLatino peopleLatinosLinkage DisequilibriumLocalized DiseaseMalignant Breast NeoplasmMalignant NeoplasmsMalignant TumorMalignant Tumor of the LungMalignant neoplasm of lungMalignant neoplasm of prostateMalignant prostatic tumorMeasuresMedicineMethodsNatureOncologyOncology CancerPaperPatient Self-ReportPerformancePersonsPlasmaPlasma SerumPopulationPopulation HeterogeneityPopulation ResearchPopulation-based researchPopulation-level researchProstate CAProstate CancerProstate malignancyPulmonary CancerPulmonary malignant NeoplasmQTLQuantitative Trait LociRegulatory ElementReproducibilityResearch PersonnelResearchersReticuloendothelial System, Serum, PlasmaRiskRisk-associated variantSamplingScreening for cancerSelf-ReportSpeedStructureTestingVariantVariationallelic frequencyallelic variantbiologiccancer cell genomecancer geneticscancer genomecancer in the coloncancer riskchromatin immunoprecipitation coupled with sequencingchromatin immunoprecipitation followed by sequencingchromatin immunoprecipitation with sequencingchromatin immunoprecipitation-seqchromatin immunoprecipitation-sequencingclinical applicabilityclinical applicationcohortdevelopmentaldisease causing variantdisease riskdisease-causing alleledisease-causing mutationdisorder riskdisproportionately affects malesdisproportionately affects mendisproportionately concentrated among mendisproportionately distributed among mendisproportionately higher among mendisproportionately impacts mendisproportionately occurs in mendiverse populationsearly cancer detectionepigeneticallyepigenome profilingepigenomic profilingepigenomicsgenetic associationgenetic variantgenome scalegenome wide associationgenome wide association scangenome wide association studygenome-widegenomewidegenomewide association scangenomewide association studygenomic variantheterogeneous populationhistone modificationimprovedinnovateinnovationinnovativeinsightinvestigate populationlow-frequency mutationlung cancermale biasmale predominancemalignancymalignant breast tumormenmen disproportionately diagnosedmen disproportionately experiencemen experience disproportionate ratesmulti-ethnicmultiethnicneoplasm/cancernew approachesnovelnovel approachesnovel strategiesnovel strategypathogenic allelepathogenic variantpolygenetic risk scorespolygenic risk scorepopulation diversitypopulation investigationpopulation level investigationpopulation specific researchpredominantly affecting menprostate cancer riskrare allelerare mutationrare variantrisk allelerisk generisk genotyperisk locirisk locusrisk variantscreening cancer patientsstudies of populationsstudy of the populationstudy populationsurvey populationtumor genomewhole genome association analysiswhole genome association study
Description preview
Multi-ancestry genome-wide association studies (GWAS) are beginning to identify cancer risk loci that are associated with genetic ancestry. Most GWAS risk loci affect regulatory DNA, and it remains challenging to determine how genetic variants at these loci alter gene regulation to confer cancer risk. Chromatin QTLs (cQTLs) are emerging as a…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click